ArticleACS medicinal chemistry letters2017

Structure-Guided Design of Novel, Potent, and Selective Macrocyclic Plasma Kallikrein Inhibitors.

Zhe Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.